Jun 18, 2020
Worldwide Attention Deficit Hyperactivity Disorder Industry (2020 to 2024) - Identify Key Drugs Marketed and Prescribed
Jun 15, 2020
FDA Permits Marketing of First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD
May 14, 2020
Clinical study finds USANA's cognitive support supplement optimizes brain function after only one use
May 13, 2020
Arbor Pharmaceuticals Announces FDA Filing Acceptance of New Drug Application (NDA) for AR19, an Investigational ADHD Prescription Stimulant Treatment Specifically Designed to Resist Physical Manipulation for Nonmedical Misuse or Abuse
May 12, 2020
Obesity Market Review 2016-2019 and Outlook 2020-2024
May 12, 2020
Narcolepsy Market Analysis 2016-2024: Pipeline, Epidemiology, Competitive Analysis, Drug Sales and Shares
Apr 17, 2020
MD Diet Combats COVID-19's Biggest Risk Factor Obesity with Telehealth
Mar 31, 2020
Saxenda® Demonstrated Improvements in BMI and Body Weight in Adolescents With Obesity
Mar 31, 2020
Lannett Begins Marketing Generic Adderall® XR
Mar 17, 2020
Quillivant XR®, QuilliChew ER® and Dyanavel® XR are 100% Made in the U.S.A. and Remain Consistently Supplied During COVID-19 Pandemic
Mar 09, 2020
Outlook on the Attention Deficit Hyperactivity Disorder (ADHD) Market to 2026
Mar 04, 2020
North American Obesity Organizations Recognize World Obesity Day
Feb 11, 2020
Teens with a History of ADHD Need Stronger Monitoring of Health Risks
Feb 07, 2020
Children with ADHD more likely to receive medication if they live in poorer areas
Jan 24, 2020
Ontario continues to improve access to treatment for children and adolescents living with ADHD who are prescribed INTUNIV XR®*
Jan 17, 2020
APSARD and Tris Pharma Announce the Inaugural Tris Research Award in ADHD
Dec 12, 2019
Lannett To Commence Marketing Generic Adderall® XR
Dec 11, 2019
RSNA: Artificial Intelligence Boosts MRI Detection of ADHD
Nov 27, 2019
Visiongain Launches Report Examining the Potential in the $17bn Attention Deficit Hyperactivity Disorder Drugs Market
Nov 07, 2019
Tris Pharma to Present Two Posters for Amphetamine Extended-Release Tablet at the 2019 Neuroscience Education Institute (NEI) Congress